Diagnostics (Jul 2022)

The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management

  • Marina Lugarà,
  • Stefania Tamburrini,
  • Maria Gabriella Coppola,
  • Gabriella Oliva,
  • Valeria Fiorini,
  • Marco Catalano,
  • Roberto Carbone,
  • Pietro Paolo Saturnino,
  • Nicola Rosano,
  • Antonella Pesce,
  • Raffaele Galiero,
  • Roberta Ferrara,
  • Michele Iannuzzi,
  • D’Agostino Vincenzo,
  • Alberto Negro,
  • Francesco Somma,
  • Fabrizio Fasano,
  • Alessandro Perrella,
  • Giuseppe Vitiello,
  • Ferdinando Carlo Sasso,
  • Gino Soldati,
  • Luca Rinaldi

DOI
https://doi.org/10.3390/diagnostics12081856
Journal volume & issue
Vol. 12, no. 8
p. 1856

Abstract

Read online

Purpose: We aimed to assess the role of lung ultrasound (LUS) in the diagnosis and prognosis of SARS-CoV-2 pneumonia, by comparing it with High Resolution Computed Tomography (HRCT). Patients and methods: All consecutive patients with laboratory-confirmed SARS-CoV-2 infection and hospitalized in COVID Centers were enrolled. LUS and HRCT were carried out on all patients by expert operators within 48–72 h of admission. A four-level scoring system computed in 12 regions of the chest was used to categorize the ultrasound imaging, from 0 (absence of visible alterations with ultrasound) to 3 (large consolidation and cobbled pleural line). Likewise, a semi-quantitative scoring system was used for HRCT to estimate pulmonary involvement, from 0 (no involvement) to 5 (>75% involvement for each lobe). The total CT score was the sum of the individual lobar scores and ranged from 0 to 25. LUS scans were evaluated according to a dedicated scoring system. CT scans were assessed for typical findings of COVID-19 pneumonia (bilateral, multi-lobar lung infiltration, posterior peripheral ground glass opacities). Oxygen requirement and mortality were also recorded. Results: Ninety-nine patients were included in the study (male 68.7%, median age 71). 40.4% of patients required a Venturi mask and 25.3% required non-invasive ventilation (C-PAP/Bi-level). The overall mortality rate was 21.2% (median hospitalization 30 days). The median ultrasound thoracic score was 28 (IQR 20–36). For the CT evaluation, the mean score was 12.63 (SD 5.72), with most of the patients having LUS scores of 2 (59.6%). The bivariate correlation analysis displayed statistically significant and high positive correlations between both the CT and composite LUS scores and ventilation, lactates, COVID-19 phenotype, tachycardia, dyspnea, and mortality. Moreover, the most relevant and clinically important inverse proportionality in terms of P/F, i.e., a decrease in P/F levels, was indicative of higher LUS/CT scores. Inverse proportionality P/F levels and LUS and TC scores were evaluated by univariate analysis, with a P/F–TC score correlation coefficient of −0.762, p p < 0.001. Conclusions: LUS and HRCT show a synergistic role in the diagnosis and disease severity evaluation of COVID-19.

Keywords